{"DataElement":{"publicId":"4383251","version":"1","preferredName":"PI-RADS Diffusion Weighted Imaging Assessed Score","preferredDefinition":"Score to represent a structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS) with a diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.","longName":"PIRADS_DWI_SC","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"4383073","version":"1","preferredName":"PI-RADS Diffusion Weighted Imaging Assessed","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence._The final result of a determination of the value, significance, or extent of.","longName":"4382371v1.0:4383071v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"4382371","version":"1","preferredName":"Prostate Imaging-Reporting and Data System","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","longName":"C116385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB2CAE4-93A8-073E-E040-BB89AD437130","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4383071","version":"1","preferredName":"Diffusion Weighted Imaging Assessment","preferredDefinition":"A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.:The final result of a determination of the value, significance, or extent of.","longName":"C111116:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffusion Weighted Imaging","conceptCode":"C111116","definition":"A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDC84AA1-9C73-FC5A-E040-BB89AD433AD9","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"ONEDATA","dateModified":"2014-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDC84AA1-9C84-FC5A-E040-BB89AD433AD9","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"7/9/14 created for C3D (Dr. Pinto) PI-RADS Protocol 14C0112. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4382605","version":"1","preferredName":"PI-RADS Diffusion Weighted Imaging Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy._A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"PIRADS_DWI_SCORE","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"5","valueDescription":"Focal area/mass of hyper SI on the high b-value images (>=b800) with reduced ADC","ValueMeaning":{"publicId":"4382606","version":"1","preferredName":"Focal area/mass of hyper SI on the high b-value images (>=b800) with reduced ADC","longName":"4382606","preferredDefinition":"Focal area/mass of hyper SI on the high b-value images (>=b800) with reduced ADC.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-06FF-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-0718-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"4","valueDescription":"Focal area(s) of reduced ADC but iso-intense SI on high b-value images (>=b800)","ValueMeaning":{"publicId":"4382607","version":"1","preferredName":"Focal area(s) of reduced ADC but iso-intense SI on high b-value images (>=b800)","longName":"4382607","preferredDefinition":"Focal area(s) of reduced ADC but iso-intense SI on high b-value images (>=b800).","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-0722-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-073B-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"3","valueDescription":"Intermediate appearances not in categories a/b or d/e.","ValueMeaning":{"publicId":"4382595","version":"1","preferredName":"Intermediate appearances not in categories a/b or d/e.","longName":"4382595","preferredDefinition":"Intermediate appearances not in categories a/b or d/e.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-05AC-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-0745-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"2","valueDescription":"Diffuse, hyper SI on >=b800 image with low ADC; no focal features, however, linear, triangular or geographical features are allowed","ValueMeaning":{"publicId":"4382608","version":"1","preferredName":"Diffuse, hyper SI on >=b800 image with low ADC; no focal features, however, linear, triangular or geographical features are allowed","longName":"4382608","preferredDefinition":"Diffuse, hyper SI on >=b800 image with low ADC; no focal features, however, linear, triangular or geographical features are allowed.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-074F-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-0768-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"1","valueDescription":"No reduction in ADC compared with normal glandular tissue. No increase in SI on any high b-value image (>=b800)","ValueMeaning":{"publicId":"4382609","version":"1","preferredName":"No reduction in ADC compared with normal glandular tissue. No increase in SI on any high b-value image (>=b800)","longName":"4382609","preferredDefinition":"No reduction in ADC compared with normal glandular tissue. No increase in SI on any high b-value image (>=b800).","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-0772-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB6E260-078B-945F-E040-BB89AD432A62","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4382604","version":"1","preferredName":"Prostate Imaging-Reporting and Data System Diffusion Weighted Imaging Score","preferredDefinition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.:A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C116385:C111116:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Imaging-Reporting and Data System","conceptCode":"C116385","definition":"A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diffusion Weighted Imaging","conceptCode":"C111116","definition":"A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-06D9-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB6E260-06EA-945F-E040-BB89AD432A62","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-08","modifiedBy":"SBREXT","dateModified":"2016-09-15","changeDescription":"7/8/14 created for C3D (Dr. Pinto) PI-RADS Protocol 14C0112. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Diffusion Weighted Imaging (D","type":"Preferred Question Text","description":"Diffusion Weighted Imaging (DWI) PI-RADS score","url":null,"context":"CCR"},{"name":"Short Text","type":"Alternate Question Text","description":"DWI PI-RADS Score","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCAF842-73BC-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeDescription":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}